Cambia

OAR on January 17, 2020

Cambia is an independent non-profit institute creating new technologies, tools and paradigms to promote change and enable innovation.

Within Australia, Cambia is registered with the Australian Securities and Invesment Commission(ASIC) in the Australian Capital Territory (ABN 82 061 897 158). Cambia is subject to regulation by ASIC and the Australian Taxation Office. Cambia is ruled as income tax exempt and is a rebatable employer for the purpose of employee fringe benefit tax. Cambia is both an Approved Research Institute (ARI) by the criteria of the Australian Taxation Office, and a Registered Research Agency (RRA), eligible for private sector R&D tax credits. For government contracting, Cambia has Central Contractor Registration (CCR) (ccrcambia), DUNS number (75-214-4378) and NCAGE code (Z0LA8).

As a not-for-profit company limited by guarantee, Cambia operates in a similar manner to other private sector institutions but with key differences associated with its public-good mission and its corresponding tax-exempt status. Cambia’s Governance Page lists the names of all its Directors, and provides the full text of Cambia’s Constitution, which is registered with the Australian Securities and Invesment Commission.

Cambia is financed by philanthropic organizations, by national and international research funding bodies, by official development assistance (ODA) and by licenses and voluntary fees associated with private sector use of Cambia’s technologies.

Cambia is affliliated with and headquartered on the Gardens Point campus of Queensland University of Technology (QUT) in Brisbane, and Cambia’s CEO, Richard Jefferson and Principal Scientist, Osmat Azzam Jefferson are tenured Professors of Science, Technology & Law at QUT.

https://cambia.org

PatSeq

OAR on January 17, 2020

Biological Toolset
Search and analyse Biological Sequences disclosed in patents

Choose among the 5 apps available to you to search and analyse the DNA, RNA and protein sequences found in patents. The Lens’ unique open PatSeq facility allows you to search, analyse and share the biological sequences disclosed in patents. This is the world’s largest publicly available database with internal transparency metrics.

https://www.lens.org/lens/bio

PatCite

OAR on January 17, 2020

Analyze Linkages Between Academic Research And Inventions

We are sure that science and technology influences and enables industry. But how do we map this and measure it? And how do we improve it? The Lens has mined the global patent literature for citations of scholarly published work, and provides free and open tools to explore which articles influence what patents, held by what institutions. Investors and funding agencies can find whether the science they fund enables outcomes for society through new inventions and products. Using this toolkit you can track, filter, sort, and link scholarly articles that are cited in patents, examine the citing patents, and discover new partners and collaborators. Influence Mapping provides an evidence base to guide decision-making and enables improved public policies and institutional practices.

https://www.lens.org/lens/patcite

The LENS Platform

OAR on January 17, 2020

What is the Lens

The Lens is an open global cyberinfrastructure to make the innovation system more efficient and fair, more transparent and inclusive.

The Lens is building an open platform for Innovation Cartography. Specifically, the Lens serves nearly all of the patent documents in the world as open, annotatable digital public goods that are integrated with scholarly and technical literature along with regulatory and business data. The Lens will allow document collections, aggregations, and analyses to be shared, annotated, and embedded to forge open mapping of the world of knowledge-directed innovation. Ultimately, this will restore the role of the patent system as a teaching resource to inspire and inform entrepreneurs, citizens and policy makers.

Within the next two years, we expect to host over 95% of the world’s patent information and link to most of the scholarly literature, creating open public innovation portfolios of individuals and institutions. Using all open source components, we are working to create open schemas by which patent documents can be used to teach and communicate, rather than confuse and intimidate.

Underlying data and analytics will be available to the public with APIs. By creating and freely sharing APIs and by building modular, standardized specifications, we can envision growing public use of innovation cartography to decrease fear, uncertainty and doubt hindering investment and enthusiasm.

https://www.lens.org/

Related: PatCite ; PatSeq